- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Regulus Therapeutics Inc+ Add to Watchlist
RGLS:US7.0200 USD 0.3500 4.75%
As of 20:10:00 ET on 09/19/2014.
Company Profile for Regulus Therapeutics Inc (RGLS)
Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulas's research consists of scientists from across the world.
Regulus Therapeutics Inc
Key Executives for Regulus Therapeutics Inc (RGLS)
|Kleanthis G XanthopoulosPresident/CEO||David SzekeresChief Bus Ofcr/Secy/Gen Cnsl|
|Paul C GrintChief Medical Officer||Neil W GibsonChief Scientific Officer|
|Mary Yaroshevsky GlanvilleSenior VP:Human Capital||Daniel R ChevallardVP:Finance & Accounting|
|Victor KnopovVP:Pharmaceutical Development||Amy ConradDirector:Investor Relations|